Plain-English translation of NCT06445517 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is one of the first human studies of a new cancer medication called . Researchers want to find out if this treatment is safe and what dose works best in people with advanced solid tumors or B-cell lymphomas that haven't responded to standard treatments. The study will help determine how the medication works in the body and whether it may help shrink tumors.
Many people with advanced cancers or lymphomas run out of standard treatment options that work for them. This medication takes a new approach to fighting cancer, and researchers need to test whether this new treatment is safe enough and effective enough to help patients like you.
You likely qualify if…
You likely don't qualify if…
During the study, you will take the medication by mouth (orally). The first phase involves a single dose on day 1, followed by daily doses in 28-day treatment cycles. You will need to visit the study clinic regularly for blood tests, imaging scans, and check-ins with the research doctor to monitor your health and how you're responding to the treatment. The study will last several months, and you'll be monitored closely for any side effects or benefits.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
China